Vancity Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-60,413
Closed -$4.36M 63
2022
Q1
$4.36M Sell
60,413
-3,860
-6% -$278K 0.52% 57
2021
Q4
$5.9M Buy
64,273
+1,921
+3% +$230K 0.68% 53
2021
Q3
$7.91M Buy
62,352
+2,644
+4% +$385K 1.01% 41
2021
Q2
$9.93M Buy
59,708
+3,225
+6% +$523K 1.39% 31
2021
Q1
$10.3M Buy
56,483
+13,223
+31% +$3.07M 1.89% 18
2020
Q4
$8.65M Buy
+43,260
New +$8.8M 1.73% 20

Other funds holding TDOC

Vancity Investment Management's TDOC Position: Q2 2022 in Review

Vancity Investment Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 60,413 shares — an estimated $4.36M sold.

Vancity Investment Management first reported a position in TDOC in Q4 2020 and held it in 6 quarters. The position peaked at $10.3M in Q1 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Vancity Investment Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Vancity Investment Management sold 60,413 Teladoc Health shares in Q2 2022, an estimated $4.36M.
  • Vancity Investment Management first reported a position in Teladoc Health in Q4 2020 and held it in 6 quarters.
  • Vancity Investment Management's Teladoc Health position peaked at $10.3M in Q1 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Vancity Investment Management's 13F filing for Q2 2022, filed 9 Aug 2022.